Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (181-190 of 350) with videos related to

Pageof 35
Sort By:
Gut|April 17, 2015
Immunogenicity to infliximab is associated with HLA-DRB1Thomas Billiet, Niels Vande Casteele, Thomas Van Stappen, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 9, 2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel DiseaseMaaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, et al.
Inflammatory Bowel Diseases|February 7, 2015
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective studyLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
The American Journal of Gastroenterology|November 14, 2012
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healingTalat Bessissow, Bart Lemmens, Marc Ferrante, et al.
Inflammatory Bowel Diseases|September 19, 2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel DiseasesZhe Li, Séverine Vermeire, Dominique Bullens, et al.
Frontiers in Immunology|January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
Stem Cell Research & Therapy|December 2, 2025
FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosisMona Farhadipour, Hui Leng, Theo Thijs, et al.
Nature Reviews. Disease Primers|September 11, 2020
Ulcerative colitisTaku Kobayashi, Britta Siegmund, Catherine Le Berre, et al.
Pageof 35

Showing results (181-190 of 350) with videos related to

Sort By:
Pageof 35
Gut|April 17, 2015
Immunogenicity to infliximab is associated with HLA-DRB1Thomas Billiet, Niels Vande Casteele, Thomas Van Stappen, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 9, 2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel DiseaseMaaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, et al.
Inflammatory Bowel Diseases|February 7, 2015
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective studyLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
The American Journal of Gastroenterology|November 14, 2012
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healingTalat Bessissow, Bart Lemmens, Marc Ferrante, et al.
Inflammatory Bowel Diseases|September 19, 2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel DiseasesZhe Li, Séverine Vermeire, Dominique Bullens, et al.
Frontiers in Immunology|January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
Stem Cell Research & Therapy|December 2, 2025
FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosisMona Farhadipour, Hui Leng, Theo Thijs, et al.
Nature Reviews. Disease Primers|September 11, 2020
Ulcerative colitisTaku Kobayashi, Britta Siegmund, Catherine Le Berre, et al.
Pageof 35